Article info
PostScript
Letter
Metformin and risk of hepatocellular carcinoma: are statins the missing link?
-
Correspondence to
Dr Siddharth Singh, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA; singh.siddharth2{at}mayo.edu
Citation
Metformin and risk of hepatocellular carcinoma: are statins the missing link?
Publication history
- Received November 28, 2012
- Accepted November 28, 2012
- First published December 22, 2012.
Online issue publication
April 30, 2013
Article Versions
- Previous version (22 December 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions